Simon Pahnke
Forskare vid Institutionen för medicinska vetenskaper; Hematologi
- Mobiltelefon:
- 073-316 00 26
- E-post:
- simon.pahnke@medsci.uu.se
- Besöksadress:
- Akademiska sjukhuset, ing 101, plan 4
751 85 Uppsala - Postadress:
- Akademiska sjukhuset, ing 100, plan 2
751 85 Uppsala
Ladda ned kontaktuppgifter för Simon Pahnke vid Institutionen för medicinska vetenskaper; Hematologi
Läkare vid Institutionen för immunologi, genetik och patologi; Kliniska verksamheter; Klinisk onkologi
- Mobiltelefon:
- 073-316 00 26
- E-post:
- simon.pahnke@igp.uu.se
- Besöksadress:
- Akademiska sjukhuset, ingång 100/101
751 85 Uppsala - Postadress:
- Akademiska sjukhuset, ingång 100/101
751 85 Uppsala
Post doc. vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerprecisionsmedicin; Forskargrupp Ingrid Glimelius
- Mobiltelefon:
- 073-316 00 26
- Besöksadress:
- Akademiska sjukhuset, ingång 100/101
751 85 Uppsala - Postadress:
- Akademiska sjukhuset, ingång 100/101
751 85 Uppsala
Mer information visas för dig som medarbetare om du loggar in.
Publikationer
Urval av publikationer
- Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation (2019)
- Short-term side effects and attitudes towards second donation (2018)
- Differences in side effects, sick leave and the will to donate again (2016)
Senaste publikationer
- Secondary malignancies among mantle cell lymphoma patients (2023)
- Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2 (2023)
- Worries and Psychological Well-Being in Potential Hematopoietic Stem Cell Donors Before Donation-A Swedish National Study (2023)
- No evidence for transmission of psychosis, bipolar or depressive disorder via hematopoietic stem cell transplantation (2022)
- Potential Hazards for Haematopoietic Stem Cell Donors (2022)
Alla publikationer
Artiklar
- Secondary malignancies among mantle cell lymphoma patients (2023)
- Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2 (2023)
- Worries and Psychological Well-Being in Potential Hematopoietic Stem Cell Donors Before Donation-A Swedish National Study (2023)
- No evidence for transmission of psychosis, bipolar or depressive disorder via hematopoietic stem cell transplantation (2022)
- Cancer incidence in healthy Swedish peripheral blood stem cell donors (2022)
- COVID-19 seroprevalence and clinical picture in Swedish pediatric oncology and hematology patients (2022)
- Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer (2021)
- Covid-19 intensive care admissions and mortality among swedish patients with cancer (2020)
- Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation (2019)
- Short-term side effects and attitudes towards second donation (2018)
- Differences in side effects, sick leave and the will to donate again (2016)
- Psychological Well-Being and Health in potential Donors of Hematopoietic Stem Cells before donation – A Swedish national study
- No increased incidence of cardiovascular disease in healthy Swedish peripheral blood stem cell donors
Böcker
